12-Lipoxygenase: A Potential Target for Novel Anti-Platelet Therapeutics

E-ISSN： 1875-6182|9|3|154-164

ISSN： 1871-5257

Source： Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol.9, Iss.3, 2011-07, pp. : 154-164

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Future Prospects in Anti-Platelet Therapy: A Review of Potential P2Y12 and Thrombin Receptor Antagonists

Recent Patents on Cardiovascular Drug Discovery, Vol. 3, Iss. 3, 2008-11 ,pp. : 194-200

Bentham Science Publishers

Access to resources Recommend Favorite

Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: A potential antiplatelet therapeutic target

By Gurbel Paul Antonino Mark Bliden Kevin DiChiara Joseph Suarez Thomas Singla Anand Tantry Udaya

Platelets, Vol. 19, Iss. 8, 2008-12 ,pp. : 595-604

Informa Healthcare

Access to resources Recommend Favorite

Thrombin Receptor: A Novel Target for Antiplatelet Drug Development

By Ray A. Hegde L.G. Gupta J.B.

Thrombosis Research, Vol. 87, Iss. 1, 1997-07 ,pp. : 37-50

Elsevier

Access to resources Recommend Favorite

A paradigm shift in anti-platelet therapy?

By Bonello L. Barragan P. Paganelli F.

Platelets, Vol. 19, Iss. 8, 2008-12 ,pp. : 562-564

Informa Healthcare

Access to resources Recommend Favorite

Platelet in Progression of Atherosclerosis: A Potential Target in Diabetic Patients

Current Diabetes Reviews, Vol. 1, Iss. 2, 2005-06 ,pp. : 159-165

Bentham Science Publishers

Access to resources Recommend Favorite